The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets

The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets

Cerebrovascular diseases are pathological conditions involving impaired blood flow in the brain, primarily including ischaemic stroke, intracranial haemorrhage, and subarachnoid haemorrhage. The nucleotide-binding and oligomerisation (NOD) domain-like receptor (NLR) family pyrin domain (PYD)-contain...

Full description

Bibliographic Details
Main Authors:	Rongrong Bai, Yue Lang, Jie Shao, Yu Deng, Reyisha Refuhati, Li Cui
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-05-01
Series:	ASN Neuro
Online Access:	https://doi.org/10.1177/17590914211018100

Similar Items

The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
by: Ruixiang Chen, et al.
Published: (2021-03-01)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
by: Dantong Wu, et al.
Published: (2021-08-01)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
by: Gulcin Tezcan, et al.
Published: (2021-02-01)

Cellular metabolism and the NLRP3 inflammasome as therapeutic targets in cystic fibrosis
by: Scambler, Thomas
Published: (2018)

Targeting the NLRP3 Inflammasome in Glaucoma
by: Sophie Coyle, et al.
Published: (2021-08-01)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
by: Bo-Zong Shao, et al.
Published: (2018-09-01)

Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
by: Sonia Missiroli, et al.
Published: (2021-05-01)

Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
by: Qiu-Ling Chen, et al.
Published: (2021-06-01)

The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
by: Saifudeen Ismael, et al.
Published: (2021-01-01)

NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
by: Shanshan Wei, et al.
Published: (2021-04-01)

The Potential Therapeutic Role of miR-223 in Bovine Endometritis by Targeting the NLRP3 Inflammasome
by: Gan Zhao, et al.
Published: (2018-08-01)

Targeting the NLRP3 Inflammasome via BTK
by: Alexander N. R. Weber, et al.
Published: (2021-02-01)

NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?
by: Feng Zhou, et al.
Published: (2021-01-01)

The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
by: William T. O’Brien, et al.
Published: (2020-04-01)

NLRP3 Inflammasome: Pathogenic Role and Potential Therapeutic Target for IgA Nephropathy
by: Tsai, Yu-Ling, et al.
Published: (2017)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
by: Yanhui Duan, et al.
Published: (2020-01-01)

The NLRP3 Inflammasome: Role and Therapeutic Potential in Pain Treatment
by: Hana Starobova, et al.
Published: (2020-08-01)

Targeting the NLRP3 Inflammasome in Severe COVID-19
by: Tracey L. Freeman, et al.
Published: (2020-06-01)

Targeting NLRP3 Inflammasome Activation in Severe Asthma
by: Efthymia Theofani, et al.
Published: (2019-10-01)

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
by: Mahbuba Akther, et al.
Published: (2021-08-01)

Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
by: Yi Huang, et al.
Published: (2018-04-01)

Activation of NLRP3 Inflammasome and Onset of Alzheimer’s Disease
by: Hua Bai, et al.
Published: (2021-07-01)

NLRP3 Inflammasome and Inflammatory Diseases
by: Zheng Wang, et al.
Published: (2020-01-01)

NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ
by: Yu Chen, et al.
Published: (2018-01-01)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
by: Nan Ding, et al.
Published: (2020-12-01)

Inhibiting the NLRP3 Inflammasome
by: Lina Y. El-Sharkawy, et al.
Published: (2020-11-01)

The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
by: Shyam S. Chaurasia, et al.
Published: (2018-02-01)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01)

NOVEL COMPOUNDS AS POTENTIAL ALZHEIMER'S DISEASE THERAPEUTICS AND INHIBITORS OF THE NLRP3 INFLAMMASOME
by: Chojnacki, Jeremy E
Published: (2014)

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
by: Congfei Xu, et al.
Published: (2018-10-01)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
by: Yadi Guan, et al.
Published: (2020-07-01)

NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
by: Yang Liu, et al.
Published: (2020-01-01)

Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice
by: Wu Jiang, et al.
Published: (2017-10-01)

Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
by: Ozaki E, et al.
Published: (2015-01-01)

NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?
by: Na Jiang, et al.
Published: (2021-09-01)

Vitamin D and the NLRP3 Inflammasome
by: Matthew Tunbridge, et al.
Published: (2020-11-01)

Role of the NLRP3 Inflammasome in Preeclampsia
by: Koumei Shirasuna, et al.
Published: (2020-02-01)

Regulation of NLRP3 Inflammasome by Phosphorylation
by: Nan Song, et al.
Published: (2018-10-01)

Role of the NLRP3 inflammasome in cancer
by: Maryam Moossavi, et al.
Published: (2018-11-01)

Pharmacological Inhibitors of the NLRP3 Inflammasome
by: Ayesha Zahid, et al.
Published: (2019-10-01)